/SCAL

SCAL Stock - Stem Cell Authority, Ltd.

Q: What is the analyst price target for SCAL?

Analyst price target information is not currently available for SCAL.

Q: What is SCAL's market cap?

Market capitalization information is not currently available for SCAL.

Healthcare|Medical - Care Facilities|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for SCAL

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2001

FY2002

FY2023

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-4.75

52W High$0.02

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2023	FY2002	FY2001
Revenue	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A
Gross Margin	N/A	N/A	N/A
Operating Income	$-4,230	$-41,310	$-42,200
Net Income	$-4,233	$-41,310	$-42,200
Net Margin	N/A	N/A	N/A
EPS	$0.00	$-0.01	$-0.01

Company Overview

Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton's jelly inside the umbilical cord of a newborn child. The company's technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in Fairlawn, Ohio.

Visit Website

Frequently Asked Questions about SCAL

What is SCAL's current stock price?

Stem Cell Authority, Ltd. (SCAL) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for SCAL?

No analyst price targets are currently available for this stock.

What sector is Stem Cell Authority, Ltd. in?

Stem Cell Authority, Ltd. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the OTC exchange.

What is SCAL's market cap?

Stem Cell Authority, Ltd. has a market capitalization of $0.00 billion, making it a small-cap company.

Does SCAL pay dividends?

No, Stem Cell Authority, Ltd. does not currently pay a dividend to shareholders.